Moderna, largest biotech to go public, fails to impress in market debut
06 Dec Moderna, largest biotech to go public, fails to impress in market debut
Posted at 17:08h
in
News
by KMFSLLP
Moderna Inc’s shares fell as much
as 6 percent in an upsized market debut on Friday, taking a hit
from a broader selloff in the U.S. markets spurred by investors
fretting over an economic slowdown.
Sorry, the comment form is closed at this time.